Oregon Bio is pleased to provide members with the opportunity to apply to meet with Taiho Ventures, where select members looking to raise capital will join us for a series of one-on-one meetings, scheduled to take place virtually on Thursday, May 7th.
Taiho Ventures, LLC is the strategic corporate venture capital arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharma focusing on oncology, allergy and immunology, and urology. Taiho Ventures is looking at early-stage preclinical therapeutics companies as well as platform technology for our core therapeutic areas. We will review the wide variety of modalities for both biologics and small molecules. The company will also consider the option type of investments and spin-outs, in addition to the pure equity investments.
Brought to Oregon Bio members in partnership with Biocom. The Taiho Ventures investment team will meet with pre-selected companies working in their areas of interest that align with their investment strategy.
Venture Day Agenda
- 9:00am – 5:00pm: One-on-One Meetings*
Areas of Interest:
- Drug Discovery (First-in-class or new biology-based approach)
- Innovative Platform Technologies for Drug Discovery
Drug Delivery platforms:
- Oncology (Protein Degrader, Chomatin Remodeling, Senescence, Intracellular Undruggable Target, Autophagy, Bacteriophage, Small Molecule RNA – including RNA Splicing)
- “Non-Oncology” (Including: Immunology/Allergy/Bone/Muscle/Orphan)
- Small Molecules
- Gene/Cell Therapy
Stage of Development:
- Research to Pre-IND
- IND to PoC (Opportunistic)
How to Apply:
If you are working in any of the areas of interested outlined above and would like to meet with the Taiho Ventures investment team, please submit a non-confidential corporate deck or executive summary including detailed descriptions of any program(s) you would like to discuss Liisa Bozinovic, Oregon Bio Executive Director at email@example.com no later than Thursday, April 23rd for consideration.
*Please note that you must submit an application to meet with the Taiho Ventures team; selected companies will be notified directly.